SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants AirXpanders, Inc. an Investigational Device Exemption to Begin Pivotal Study of an Investigational Tissue Expansion System for Women Undergoing Breast Reconstruction After Mastectomy